Skip to main content

Table 1 Summary of the prevalence of MRSA and hVISA in 220 S.aureus bloodstream isolates

From: Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of staphyloccocus aureus

 

S. aureus

220

MSSA

55% (121/220)

MRSA

45% (99/220)

hVISA

5.5% (12/220)

MIC50/90

1/2

1/2 (p = 0.51)a

1/2 (p = 0.46)a

1.5/2 (p = 0.03)a

agr-dysfunction

15% (33/220)

10% (12/121)

21% (21/99) (p = 0.02)b

58% (7/12) (p< 0.0005)c

  1. MIC50/90 determined by CLSI broth microdilution and the prevalence of agr-dysfunctional
  2. a MIC distribution of total clinical S.aureus versus MIC distribution of each phenotype (Mann-Whitney U)
  3. b Prevalence of agr dysfunction in MRSA isolates versus MSSA isolates (Chi-square test)
  4. c Prevalence of agr dysfunction in hVISA isolates versus VSSA isolates (Chi-square test)